Equities researchers at William Blair issued their FY2028 earnings estimates for Tempest Therapeutics in a research report ...
Stock analysts at William Blair issued their Q1 2025 EPS estimates for Neurogene in a research report issued to clients and ...
Nkarta restructures to extend its cash runway into 2029, with upcoming NKX019 clinical data readouts in H2 2025. Analysts ...
Investor's Business Daily on MSN1h
Tesla Delivers 336,681 EVs, Below Views And Lowest In Years. Tesla Stock Reverses Higher. (Live Coverage)Tesla reported first-quarter vehicle deliveries of 336,681 before Wednesday's stock market open Wednesday. That was worse ...
William Blair analyst Ross Sparenblek maintained a Buy rating on Mayville Engineering Company (MEC – Research Report) today. The company’s ...
In a report released today, Andy Hsieh from William Blair maintained a Hold rating on FibroGen (FGEN – Research Report). The company’s shares ...
William Blair Large Cap Growth Fund earns an Average ... they may cut payouts if their earnings fall. Similarly, in recent months, the strategy also had less exposure to the Yield factor than ...
The Fund seeks long-term capital appreciation. Under normal conditions, the Fund invests primarily in a diversified portfolio of equity securities, including common stocks and other forms of ...
Jeffrey Graves; President, Chief Executive Officer, Director; 3D Systems Corp Jeffrey Creech; Chief Financial Officer, Executive Vice President; 3D Systems Corp Greetings, and welcome to the 3D ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback